UTHR vs OVV Comparison

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Ovintiv is an independent oil and gas producer focused on Canada's Montney and the US' Permian basins. Historically, it has been an acquisitive producer across numerous basins and plays but has divested and exited all but two. It remains an active buyer in the remaining footprint. The firm estimates that it has up to 20 and 15 years of inventory remaining in the Montney and Permian basins, respectively.